Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression

Plastic and Reconstructive Surgery

Volumn 103, Issue 2, 1999, Pages 536-547

  Mehrara, Babak J ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; BONE TURNOVER; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; ENCHONDRAL OSSIFICATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; OSTEOTOMY; PRIORITY JOURNAL; RAT; SURGICAL TECHNIQUE; TISSUE DISTRIBUTION;

ANIMALS; BLOTTING, NORTHERN; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCALCIN; OSTEOGENESIS, DISTRACTION; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032939459     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199902000-00026     Document Type: Article

References (106)

1. Ilizarov, G. A. The tension-stress effect on the genesis and growth of tissues: Part I. The influence of stability of fixation and soft-tissue preservation. Clin. Orthop. 238: 249, 1989.
2. Ilizarov, G. A. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin. Orthop. 239: 263, 1989.
3. Ilizarov, G. A. Clinical application of the tension-stress effect for limb lengthening. Clin. Orthop. 250: 8, 1990.
4. De Bastiani, G., Aldegheri, R., Renzi-Brivio, L., and Trivella, G. Limb lengthening by callus distraction (callostasis).J. Ped. Orthop. 7: 129, 1987.
5. Fischgnmd, J., Paley, D., and Suter, C. Variables affecting time to bone healing during limb lengthening. Clin. Orthop. 301: 31, 1994.
6. Kawamura, B. Limb lengthening. Orthop. Clin. North. Am. 9: 155, 1978.
7. Price, C. T., and Cole, J. D. Limb lengthening by callotasis for children and adolescents: Early experience. Clin. Orthop. 250: 105, 1990.
8. Costantino, P. D., and Friedman, C. D. Distraction osteogenesis: Applications for mandibular regrowth. Otolaryngol. Clin. North Am. 24: 1433, 1991.
9. Cohen, S. R., Rutrick, R. E., and Burstein, F. D. Distraction osteogenesis of the human craniofacial skeleton: Initial experience with a new distraction system. J. Craniofac. Surg. 6: 368, 1995.
10. Klein, C., and Howaldt, H. P. Correction of mandibular hypoplasia by means of bidirectional callus distraction. JCraniofac. Surg. 7: 258, 1996.
11. McCarthy, J. G., Schreiber, J., Karp, N., Thorne, C. H., and Grayson, B. H. Lengthening of the human mandible by gradual distraction. Plast. Reconstr. Surg. 89:1, 1992.
12. McCarthy, J. The role of distraction osteogenesis in the reconstruction of the mandible in unilateral craniofacial microsomia. Clin. Plast. Surg. 21: 625, 1994.
13. Molina, F., and Ortiz Monasterio, F. Mandibular elongation and remodeling by distraction: A farewell to major osteotomies. Plast. Reconstr. Surg. 96: 825, 1995.
14. Ortiz Monasterio, F., Molina, F., Andrade, L., et al. Simultaneous mandibular and maxillary distraction in hemifacial microsomia in adults: Avoiding occlusal disasters. Plast. Reconstr. Surg. 100: 852, 1997.
15. Pensler, J. M., Goldberg, D. P., Lindell, B., and Carroll, N. C. Skeletal distraction of the hypoplastic mandible. Ann. Plast. Surg. 34: 130, 1995.
16. Polley, J. W., and Figueroa, A. A. Management of severe maxillary deficiency in childhood and adolescence through distraction osteogenesis with an external, adjustable, rigid distraction device. J. Craniofac. Surg. 8: 181, 1997.
17. Rachmiel, A., Levy, M., and Laufer, D. Lengthening of the mandible by distraction osteogenesis: A report of cases.J. OralMaxillofac. Surg. 53: 838, 1995.
18. Rowe, N., Mehrara, B.J., Dudziak, M. E., et al. Rat mandibular distraction osteogenesis: Parti. Histologie and radiographie analysis. Plast. Reconstr. Surg. 102: 2022, 1998.
19. Waanders, N. A., Senunas, L. E., Steen, H., Goulet,J. A., Bonadio.J., and Goldslein, S. A. Bone formation in distraction osteogenesis histologie and immunohistochemical findings. Trans. Orthop. Res. Soc. 18: 380, 1994.
20. Komuro, Y., Takato, T., Harii, K., and Yonemara, Y. The histologie analysis of distraction osteogenesis of the mandible in rabbits. Plast. Reconstr. Surg. 94: 152, 1994.
21. Ganey, T. M., Klotch, D.W., Slater-Haase, A. S., and Sasse, J. Evaluation of distraction osteogenesis by scanning electron microscopy. Otolaryngol. Head Neck Surg. Ill: 265, 1994.
22. Ganey, T. M., Klotch, D. W., Sasse, J., Ogden, J. A., and Garcia, T. Basement membrane of blood vessels during distraction osteogenesis. Clin. Orthop. 301: 132, 1994.
23. Fisher, E., Stafienberg, D. A., McCarthy, J. G., Miller, D. C., and Zeng,J. Histopathologic and biochemical changes in the muscles affected by distraction osteogenesis of the mandible. Plast. Reconstr. Surg. 99: 366, 1997.
24. Aronson.J., in M. W. Chapman (Ed.), Operative Orthopaedics. Philadelphia: Lippincott, 1993.
25. Aronson.J., Harrison, B. H., Stewart, C. L., and Harp, J. H., Jr. The histology of distraction osteogenesis using different external fixators. Clin. Orthop. 241:110, 1989.
26. Karp, N. S., McCarthy, J. G., Schreiber, J. S., Sissons, H. A., and Thorne, C. H. Membranous bone lengthening: A serial histological study. Ann. Plast. Surg. 29: 2, 1992.
27. Ilizarov, G. Transosseous Osteosynthesis. Theoretical and Clinical Aspects of the Regeneration and Growth of Tissue. Berlin: Springer-Verlag, 1992.
28. Ippolito, E., Peretti, G., Bellocci, M., et al. Histology and ultrastructure of arteries, veins, and peripheral nerves during limb lengthening. Clin. Orlhop. 308: 54, 1994.
29. Linkhart, T. A., Mohan, S., and Baylink, D. J. Growth factors for bone growth and repair: IGF, TGF-beta, and BMP. Bone 19: IS, 1996.
30. Mundy, G. R. Factors which stimulate bone growth in vivo. Growth Regul. 3: 129, 1993.
31. Centrella, M., McCarthy, T. L., and Canalis, E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblastenriched cell cultures from fetal rat bone.J. Biol. Chem. 262: 2869, 1987.
32. Centrella, M., Horowitz, M., Wozney.J., and McCarthy, T. Transforming growth factor-B gene family members and bone. Endocrinol. Rev. 15: 27, 1994.
33. Hayamizu, T. F., Sessions, S. K., Wanek, N., and Bryant, S. V. Effects of localized application of transforming growth factor beta-1 on developing chick limbs. Dev. Biol. 145: 164, 1991.
34. Joyce, M. E., Jingushi, S., and Bolander, M. E. Transforming growth factor beta in the regulation of fracture repair. Orthop. Clin. North Am. 21: 199, 1990.
35. Joyce, M. E., Roberts, A. B., Sporn, M. B., and Bolander, M. E. Transforming growth factor-B in the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol. 110:2195, 1990.
36. Harris, S. E., Bonewald, C. F., Harris, M. A., et al. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res. 9: 855, 1994.
37. Dodds, R. A., Merry, K-, Littlewood, A., and Gowen, M. Expression of mRNA for ILl-beta, IL6, and TGF-betal in developing human bone and cartilage. JHistochem. Cytochem. 42: 733, 1994.
38. Lind, M., Schumacker, B., Soballe, K., KellerJ., Meisen, F., and Bunger, C. Transforming growth factor beta enhances fracture healing in rabbit tibiae. Ada Orthop. Scand. 64: 553, 1993.
39. Robcy, P. G., Young, M. F., Flanders, K. C., et al. Osteoblasts synthesize and respond to transforming growth factor-type B (TGF-B) in vitro. J Cell Biol. 106: 457, 1987.
40. Thorp, B. H., Anderson, L, andjakowlew, S. B. Transforming growth factor-Bl, -B2 and -B3 in cartilage and bone cells during endochondral ossification in the chick. Development 114: 907, 1992.
41. Beck, L. S., Amanto, E. P., Xu, Y., et al. TGF-betal induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-betal.J. Bone Miner. Res. 8: 753, 1993.
42. Sandberg, M. M., Aro, H. T., and Vuorio, E. I. Gene expression during bone repair. Clin. Orihop. 289: 292, 1993.
43. Hiltunen, A., Aro, H. T., and Vuorio, E. Regulation of extracellular matrix genes during fracture healing in mice. Clin. Orthop. 297: 23, 1993.
44. Lane, J. M., Suda, M., von der Mark, K., and Timpl, R. Immunofluorescent localization of structural collagen types in endochondral fracture repair. J. Orihop. Res. 4: 318, 1986.
45. Multimaki, P., Aro, H., and Vuorio, E. Differential expression of fibrillar collagen genes during callus formation. Biochem. Biophys. Res. Commun. 142: 536, 1987.
46. Sandberg, M., Aro, H., Multimaki, P., Aho, H.J., and Vuorio, E. In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus. J. Bone Joint Surg. 71A: 69, 1989.
47. Bronckers, A., Gay, S., Finkelman, R., and Butler, W. Developmental appearance of Gla proteins (osteocalcin) and alkaline phosphatase in tooth germs and bones of the rat.J. Bone Miner. Res. 2: 361, 1987.
48. Desbois, C., and Karsenty, G. Osteocalcin cluster: Implications for functional studies. J. Cell Biochem. 57: 379, 1995.
49. Hauschka, P., Lian, J., Cole, D., and Gundberg, C. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev. 69: 990, 1989.
50. Hauschka, P. V., and Wians, F. H., Jr. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat. Rec. 224: 180, 1989.
51. Lian, J. B., and Gundberg, C. M. Osteocalcin: Biochemical considerations and clinical applications. Clin. Orthop. 226: 267, 1988.
52. Clemens, T. L., Tang, H., Maeda, S., et al. Analysis of Osteocalcin expression in transgenic mice reveals a species specific difference in Vitamin D regulation of mouse and human Osteocalcin genes. J. Bone Miner. Res. 12: 1570, 1997.
53. Noda, M. Transcriptional regulation of Osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. Endocrinology 124: 612, 1989.
54. Ikeda, T., Shigeno, C., Kasai, R., et al. Ovariectomy decreases the mRNA levels of transforming growth factor beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo. Biochem. Biophys. Res. Commun. 194: 1228, 1993.
55. Pirskanen,A.,Jaaskelainen,T.,andMaenpaa, P. H. Effects of transforming growth factor beta 1 on the regulation of Osteocalcin synthesis in human MG-63 osteosarcoma cells.J. Bone Miner. lies. 9: 1635, 1994.
56. Staal, A., Geertsma-Kleinekoort, W., Van Den Bernd, G., et al. Regulation of Osteocalcin production and bone résorption by 1,25-dihydroxyvitamin D3 in mouse long bones: Interaction with the bone-derived growth factors TGF-B and IGF-I. JBone Miner. Res. 13: 36, 1998.
57. Banerjee, C., Stein, J. L., Van Wijnen, A.J., Frenkel, B., Lian, J. B., and Stein, G. S. Transforming growth factor-beta 1 responsiveness of the rat Osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology 137: 1991, 1996.
58. Mehrara, B.J., Mackool, K.J., McCarthy, J. G., Gittes, G. K., and Longaker, M. T. Immunolocalization of basic fibroblast growth factor, and fibroblast growth factor receptor-1 and 2 in rat cranial sutures. Plant. Reconstr. Surg. 102: 1805, 1998.
59. Roth, D. A., Longaker, M. T., McCarthy, J. G., et al. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (l, /32, 3) during rat cranial suture fusion. JBone Miner. lies. 12: 311, 1997.
60. Roth, D. A., Gold, L. I., Han, V. K. M., et al. Immunolocalization of transforming growth factor beta-1, beta-2, and beta-3 and insulin-like growth factor I in premature cranial suture fusion. Plast. Reconstr. Surg. 99: 300, 1997.
61. Massague.J. TGF-beta signaling: Receptors, transducers, and Mad proteins. Cell 85: 947, 1996.
62. Massague.J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6: 597, 1990.
63. Dallas, S. L., Miyazono, K., Skerry, T. M., Mundy, G. R., and Bonewald, L. F. Dual role for the latent transforming growth Factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J. Cell Biol. 131: 539, 1995.
64. Bonewald, L. F., Wakefield, L., Oreffo, R., Escobedo, A., Twardzik, D. R., and Mundy, G. R. Latent forms of transforming growth factor-beta (TGF-beta) derived from bone cultures: Identification of a naturally occurring 100-KDa complex with similarity to recombinant latent TGF-beta. Mol. Endocrinol. 5: 741, 1991.
65. Seydin, S., Thomas, T., Thompson, A., Rosen, D., and Piez, K. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc. Natl. Acad. Set. USA 82: 2267, 1985.
66. Nilsen-Hamilton, M. Transforming growth factor-beta and its actions on cellular growth and differentiation. Curr. Top. Dev. Dial. 24: 95, 1990.
67. Carcamo,J., Zentella, A., and Massague.J. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation with the receptor complex. Mol. Cell. Biol. 15: 1573, 1995.
68. Heldin, C. H., Miyazono, K., and ten Dijke, P. TGFbeta signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465, 1997.
69. Wrana, J. L., Attisano, L., Weiser, R., Ventura, F., and Massague, J. Mechanisms of activation of the TGFbeta receptor. Nature 370: 341, 1994.
70. Nakao, A., Imamura, T., Souchelnytskyi, S., et al. TGFbeta receptor-mediated signaling through Smad2, SmadS and Smad4. EMBOJ. 16: 5353, 1997.
71. Wieser, R., Wrana,J. L., and Massague.J. GS domain mutations that constitutive!)'activate TBR-I, the downstream signaling component in the TGF-beta receptor complex. EMBOJ. 14: 2199, 1995.
72. Mucsi, I., and Goldberg, H.J. Dominant-negative SMAD-3 interferes with transcriptional activation by multiple agonists. Biochem. Biophys. Res. Commun. 232: 517, 1997.
73. Kretzschmar, M., Liu, F., Hâta, A., Doody, J., and Massague, J. The TGF-beta family mediator Smadl is phosphorylated directly and actuated functionally by the BMP receptor kinase. Genes Dev. 11: 984, 1997.
74. Baker.J. C., and Harland, R. M. From receptor to nu-cleus: The Smad pathway. Curr. Opin. Genet. Dev. 7: 467, 1997.
75. Hughes, F.J., Aubin.J. E., and Heersche,J. N. M. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta. Bone Miner. 19: 63, 1992.
76. Hanazawa, S., Takeshita, A., Tsukamoto, Y., Kawata, Y., Takara, K., and Kitano, S. Transforming growth factor-beta induced gene expression of monocyte chemoattractant JE in mouse osteoblastic cells, MC3T3El. Biochem. Biophys. Res. Commun. 180: 1130, 1991.
77. Datta, H. K., Zaidi, M., Champaneri, J. B., and Maclntyre, I. Transforming growth factor-beta induced mitogenesis of human bone cancer cells. Biochem. Biophys. lies. Commun. 161: 672, 1989.
78. PfeilshifterJ.,Wolf, O., Nauman, A., Minne, H., Mundy, G., and Ziegler, R. Chemotactic response of osteoblast-like cells to transforming growth factor B. JBone Miner. Res. 5: 825, 1990.
79. Lucas, P., and Caplan, A. Chemotactic response of embryonic limb bud mesenchymal cells and muscle derived fibroblasts to transforming growth factor B. Connect. Tissue Res. 18: 51, 1983.
80. Ritzenthaler, J., Goldstein, R., Fine, A., Lichtler, A., Rowe, D., and Smith, B. Transforming growth factor beta activation elements in the distal promoter regions of the rat alpha 1 type 1 collagen gene. Biochem. J. 280: 157, 1991.
81. Rossi, P., Karsenty, G., Roberts, A
82. Chung, K., Agarwal, A., Uitto, J., and Mauviel, A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (CollA2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271: 3272, 1996.
83. Macnab, I., and DeHass, W. C. The role of the periosteal blood supply in the healing of fractures of the tibia. Clin. Orthop. 105: 27, 1974.
84. Aronson, J., Harp,J. H., Walker, C. W., and Dalryinple, G. V. Blood flow, bone formation and mineralization during distraction osteogenesis. Trans. Orthop. Res. Soc. 15: 589, 1990.
85. Aronson, J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin. Orthop. 301: 124, 1994.
86. Ham, A. W. Some histophysiological problems peculiar to calcified tissues.J. Bone Joint Surg. 34A: 701, 1952.
87. Klotch, D. W., Ganey, T. M., Slater-Hasse, A., and Sasse, J. Assessment of bone formation during osteogenesis: A canine model. Ololaryngol. Head Neck Surg. 112: 291, 1995.
88. Pertovaara, L., Saksela, O., and Alitalo, K. Enhanced bFGF gene expression in response to transforming growth factor-beta stimulation of AKR-2B cells. Growth Factors 9: 81, 1993.
89. Pertovarra, L., Kaipainen, A., Mustonen, T., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. JBiol. Chem. 269: 6271, 1994.
90. Koochekpour, S., Merzak, A., and Pilkington, C. Vascular endothelial growth factor production is stimu-lated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett. 102: 209, 1996.
91. Donovan, D., Harmey, J., Toomey, D., Osborne, D., Redmond, H., and Bouchier-Hayes, D. TGF beta-1 regulation of VEGF production by breast cancer cells. Ann. Surg. Oncol. 4: 6211997.
92. Brogi, E., Wu, T., Namiki, A., and Isner.J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649, 1994.
93. Pepper, M. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8: 21, 1997.
94. Calvo, M. S., E>TC, D. R., and Griindberg, C. M. Molecular basis and clinical application of biological markers of bone turnover. Endocr. Rev. 17: 333, 1996.
95. Grundberg, C., Hauschka, P., Lian, J., and Gallop, P. Osteocalcin: Isolation, characterization, and detection. Methods Enzymol. 197: 516, 1984.
96. Ducy, P., Desbois, C., Boyce, B., et al. Increased bone formation in osteocalcin-deficient mice. Nature 382: 448, 1996.
97. Staal, A., Geertsma-Kleinekoort, W., Van Den Bernd, G., et al. Regulation of osteocalcin production and bone résorption by 1,25-dihydroxyvitamin D3 in mouse long bones: Interaction with the bone-derived growth factors TGF-B, and IGF-I.J. Bone Miner. Res. 13: 36, 1988.
98. Banerjee, C., Stein.J. L., Van Wijnen, A.J., Frenkel, B., Lian.J. B., and Stein, G. S. Transforming growth factor-beta 1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology 137: 1991, 1996.
99. Tontonoz, P., Nagy, L., Alvarez,J. G., Thomazy, V. A., and Evans, R. M. PPARgamma promotes monocyteJ macrophage differentiation and uptake of oxidized LDL. &93:241, 1998.
100. Simonet, W. S., Lacey, D. L., Dunstan, C. R., et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309, 1997.
101. Lacey, D. L., Timms, E., Tan, H. L., et al. Osteoprotcgerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cc#93: 165, 1998.
102. Gilmour, D., Lyon, G., Carlton, M., et al. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age onset cataract formation and distruption of the lenz. EMBO J. 17: 1860, 1998.
103. Ihu, W., Malloy, P., Delvin, E., Chabot, G., and Feldman, D. Hereditary 1,25-dihydroxy vitamin D-resistant rickets due to an opal mutation causing premature termination of vitamin D receptor. JBone Miner. Res. 13: 259, 1998.
104. Thompson, D., Lum, K., Nyga, S., et al. The derivation and characterization of stromal cell lines from the bone marrow of P53-/- mice: New insights into osteoblast and adipocyte differentiation. JBone Miner. Res. 13: 195, 1998.
105. Flannage, R., Tamnariello, S.,Joplin, K., Cikra-Ireland, R., and Denlinger, D. Diaphase-specific gene expression in pupae of the flesh fly sacrophageus Crassipalpis. Proc. Natl. Acad. Sci. U.S.A. 95: 5616, 1998.
106. Henning, K., Moskowitz, N., Ashlock, M., and Lu, P. Humanizing the yeast telomerase template. Proc. Natl. Acad. Sci. U.S.A. 95: 5667, 1998.